Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis
Amanda L. Wright, Paul A. Della Gatta, Sheng Le, Britt A. Berning, Prachi M. Mehta, Kelly R. Jacobs, Hossai Gul, Rebecca San Gil, Thomas J. Hedl, Winonah R. Riddell, Owen T. Watson, Sean S. Keating, Juliana Venturato, Roger S. Chung, Julie D. Atkin, , Adam K. Walker
This study shows riluzole does not improve disease outcomes in a mouse model of ALS with cytoplasmic TDP-43 pathology.
European Journal of Neuroscience · Aug 13, 2021Peer-reviewedNeuroscience